Clinical trial · Observational
A Case-control Study Comparing Glycaemic Control in Pancreatic Cancer Patients vs Healthy Matched Individuals.
A Case-control Study Comparing Glycaemic Control in Pancreatic Cancer Patients Versus Age Matched Healthy Individuals Using Continuous Glucose Monitors.
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The aim of this study is to continuously monitor blood glucose concentrations for a 7-day period in pancreatic cancer patients whilst undergoing their typical daily routines and to compare this to age matched healthy individuals. The investigators plan to carry out the study on a small subset of patients, up to 30 with pancreatic cancer (15 not undergoing chemotherapy and 15 undergoing chemotherapy) and 15 healthy individuals.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Pancreatic Cancer | Malignant Pancreatic Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (4)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Activity tracker | Device | — | UNRESOLVED |
| Continuous glucose monitors | Device | — | UNRESOLVED |
| Food Diary | Behavioral | — | UNRESOLVED |
| Questionnaires | Behavioral | — | UNRESOLVED |
Design
Arms and outcomes
Arms (3)
- label
- Healthy participants
- description
- Continuous glucose monitors will be fitted for 7 days, along with activity trackers and a food diary to monitor the impact of these factors on blood glucose concentrations. Participants will also complete questionnaires related to health inequalities and quality of life.
- interventionNames
- Device: Continuous glucose monitors
- Device: Activity tracker
- Behavioral: Food Diary
- Behavioral: Questionnaires
- label
- Pancreatic cancer patients undergoing chemotherapy
- description
- Continuous glucose monitors will be fitted for 7 days, along with activity trackers and a food diary to monitor the impact of these factors on blood glucose concentrations whilst they are undergoing chemotherapy. Participants will also complete questionnaires related to health inequalities and quality of life.
- interventionNames
- Device: Continuous glucose monitors
- Device: Activity tracker
- Behavioral: Food Diary
- Behavioral: Questionnaires
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
- Maximum age
- 85 Years
Show eligibility criteria text
Pancreatic cancer patients Inclusion Criteria: * Aged 18-85 * Sex: male/female * Radiological/tissue cancer diagnosis * World Health Organisation performance status of 2 or below * Patients with jaundice must have jaundice relieved before participating Exclusion Criteria: * Pregnancy * Planned surgery within the 7 days of wearing the monitor * Emergency surgery * Part of any other trial with similar interventions * Any musculoskeletal, cardiovascular, or neurological disorder that could put them at risk during the protocol. * World Health Organisation performance status of above 2. * Have diabetes at the point of diagnosis. Healthy control group Inclusion: * Aged 18-85 * No serious underlying health conditions * Age matched to pancreatic cancer patients Exclusion: * Take any medications which may alter blood glucose concentrations or insulin/glucagon concentrations, regular paracetamol intake during the study period, corticosteroids, thyroid hormones, or any anti-diabetes medication including insulin and oral hypoglycaemics. * Pregnant
References
Publications (0)
Data not yet available